Total Funding
77
69
Total FundingSeries B raised
Growth Score
-9 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
25828
Amphista Therapeutics operates as a biopharmaceutical company.
- Lisa Butler: Senior Vice President Clinical OperationsPast Role: AstraZeneca, Senior Director, Head of Study Leadership, Early Oncology Clinical
- Alexandra Sevko: VP Translational SciencePast Role: Prokarium, Director, Translational Research
About the Company
Amphista Therapeutics operates as a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins.
